Home › Funds › ADAR1 Capital Management, LLC › OVID

ADAR1 Capital Management, LLC position in OVID

OVID THERAPEUTICS INC · Health Care

ADAR1 Capital Management, LLC reported holding 4,560,813 shares of OVID (OVID THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$11.4M, representing 0.62% of its reported portfolio and ranking #43 among its reported holdings. ADAR1 Capital Management, LLC has disclosed OVID holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)4.56M sh
Reported value held$11.36M
Portfolio Weight0.62%
First reportedQ4 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's OVID position evolved

ADAR1 Capital Management, LLC first disclosed a stake in OVID in Q4 2023 at 13,246 shares (US$43K). The position peaked in Q2 2026 at 7,417,479 shares, worth US$20.0M. Across 12 filings, ADAR1 Capital Management, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,560,813 shares valued at US$11.4M — a reduction of -2,856,666 shares quarter over quarter.. Notable position changes include a 97% increase in Q3 2024 (shares fell 21% over the following quarter), a 246% increase in Q4 2024 (shares fell 67% over the following quarter), a 33257% increase in Q4 2025 (shares rose 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 13.25K $42.65K New
Q1 2024 16.45K $50.16K Add
Q2 2024 19.19K $14.76K Add
Q3 2024 37.74K $44.54K Add
Q4 2024 130.53K $121.88K Add
Q1 2025 115.87K $36.14K Reduce
Q2 2025 115.87K $38.23K Hold
Q3 2025 12.85K $16.70K Reduce
Q4 2025 4.29M $6.98M Add
Q1 2026 4.54M $10.09M Add
Q2 2026 7.42M $19.95M Add
Q3 2026 4.56M $11.36M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OVID and 13F data

OVID (OVID THERAPEUTICS INC) is a Health Care company. 51 other funds we track also report a position in OVID — the largest reported positions include Affinity Asset Advisors, LLC (US$25.3M), SILVERARC CAPITAL MANAGEMENT, LLC (US$14.8M), Ikarian Capital, LLC (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OVID

All OVID fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held OVID?

ADAR1 Capital Management, LLC has disclosed OVID holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is ADAR1 Capital Management, LLC's current position in OVID?

As of Q3 2026, ADAR1 Capital Management, LLC holds 4.56M shares of OVID (OVID THERAPEUTICS INC), valued at $11.36M, representing 0.62% of its reported portfolio and ranking #43.

Has ADAR1 Capital Management, LLC been buying or selling OVID?

In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC reduced its position in OVID. The position peaked in Q2 2026 at 7.42M shares.

Which other funds hold OVID?

Other major institutional holders of OVID include Affinity Asset Advisors, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, Ikarian Capital, LLC, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.